Macrolides
    1.
    发明申请
    Macrolides 失效
    大环内酯类

    公开(公告)号:US20060135447A1

    公开(公告)日:2006-06-22

    申请号:US11313523

    申请日:2005-12-21

    IPC分类号: A61K31/7052 C07H17/08

    CPC分类号: C07H17/08

    摘要: Macrolide compounds per se, as shown below and defined herein, and their use, e.g., as antibacterial and antiprotozoal agents in animals, including humans: Also disclosed are methods of preparing the compounds, intermediates, and pharmaceutical compositions thereof, and methods of treating or preventing disease by administering the compounds to subjects in need. This abstract is only an excerpt and is not limiting of the invention.

    摘要翻译: 大环内酯类化合物本身,如下文所示和定义,以及它们在动物(包括人)中作为抗细菌剂和抗原虫药的用途:还公开了制备化合物,中间体及其药物组合物的方法,以及治疗或 通过将化合物给予需要的受试者来预防疾病。 该摘要仅是摘录而不是本发明的限制。

    Macrolides
    4.
    发明授权
    Macrolides 失效
    大环内酯类

    公开(公告)号:US07462600B2

    公开(公告)日:2008-12-09

    申请号:US11313523

    申请日:2005-12-21

    IPC分类号: A61K31/70 C07H17/08

    CPC分类号: C07H17/08

    摘要: Macrolide compounds per se, as shown below and defined herein, and their use, e.g., as antibacterial and antiprotozoal agents in animals, including humans: Also disclosed are methods of preparing the compounds, intermediates, and pharmaceutical compositions thereof, and methods of treating or preventing disease by administering the compounds to subjects in need. This abstract is only an excerpt and is not limiting of the invention.

    摘要翻译: 大环内酯类化合物本身,如下文所示和定义,以及它们在动物(包括人)中作为抗细菌剂和抗原虫药的用途:还公开了制备化合物,中间体及其药物组合物的方法,以及治疗或 通过将化合物给予需要的受试者来预防疾病。 该摘要仅是摘录而不是本发明的限制。

    Macrolide antibiotics
    6.
    发明授权
    Macrolide antibiotics 失效
    大环内酯抗生素

    公开(公告)号:US06809080B2

    公开(公告)日:2004-10-26

    申请号:US09892081

    申请日:2001-06-26

    IPC分类号: A61K3170

    CPC分类号: C07H17/08

    摘要: This invention relates to compounds of the formula and to pharmaceutically acceptable salts, prodrugs, and solvates thereof wherein X, Y, R1, R2, R3, R4, and R6 are as defined herein. The compounds of formula I are antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula I, methods of making the compounds, and to methods of treating bacterial and protozoal infections by administering the compounds.

    摘要翻译: 本发明涉及下式的化合物及其药学上可接受的盐,前药和溶剂化物,其中X,Y,R 1,R 2,R 3,R 4和R 6如 本文定义。 式I化合物是可用于治疗各种细菌和原生动物感染的抗细菌剂和抗原虫药,以及与这种感染有关的疾病。 本发明还涉及含有式I化合物的药物组合物,制备化合物的方法,以及通过施用化合物治疗细菌和原生动物感染的方法。

    Amidine process
    10.
    发明授权
    Amidine process 失效
    脒法

    公开(公告)号:US4567256A

    公开(公告)日:1986-01-28

    申请号:US658236

    申请日:1984-10-05

    IPC分类号: C07D487/14 C07D403/04

    CPC分类号: C07D487/14

    摘要: 9a-Methoxymitosane derivatives having the amidino group at one or both of the 7-position and the carbamoyl-N positions are prepared by reaction of mitomycin A, mitomycin C, or an N.sup.1a -substituted analog thereof with an amide acetal, iminothioether, halomethyleniminium halide, or iminohalide salt.

    摘要翻译: 通过丝裂霉素A,丝裂霉素C或其N1a取代的类似物与酰胺缩醛,亚氨基硫醚,卤代亚甲基亚胺鎓卤化物的反应制备具有位于7-位和氨基甲酰基-N位置的一个或两个具有脒基的9a-甲氧基二十烷体衍生物 ,或亚氨基卤盐。